Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients

被引:0
作者
Taraneh Rajaei
Hamid Farajifard
Seyed Abdolrahim Rezaee
Mahmoud Reza Azarpazhooh
Mahmoud Mahmoudi
Narges Valizadeh
Houshang Rafatpanah
机构
[1] Mashhad University of Medical Sciences,Immunology Research Center, Division of Inflammation and Inflammatory Diseases, Faculty of Medicine
[2] Tehran University of Medical Sciences,Department of Immunology, Faculty of Medicine
[3] Mashhad University of Medical Sciences,Department of Neurology, Ghaem Hospital
[4] Mashhad University of Medical Sciences,Immunology Research Center
来源
Medical Microbiology and Immunology | 2019年 / 208卷
关键词
HTLV-1; HAM/TSP; CXCR1; CXCR2;
D O I
暂无
中图分类号
学科分类号
摘要
One of the prominent features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the excessive recruitment of leukocytes to the central nervous system (CNS), which leads to an inflammatory response—with chemokines and their receptors playing the main role in this recruitment. The aim of the study was to examine the relation of CXCR1 and CXCR2, both of which are involved in the trafficking of lymphocytes into the CNS, with the outcome of HTLV-1 infection. The mRNA levels of CXCR1 and CXCR2 were examined in peripheral blood mononuclear cells (PBMCs) of HAM/TSP patients, HTLV-1 asymptomatic carriers (ACs), and healthy controls (HCs). Furthermore, the frequency of CD4+ and CD8+ T cells expressing CXCR1 and CXCR2 was evaluated in the studied groups. The results of the present study showed a substantial increase in the mean mRNA expression of CXCR2 in the HAM/TSP patients compared to the HCs and ACs (p < 0.001). A positive correlation was also found between PVL and CXCR2 mRNA expression in the total population of HTLV-1-infected subjects (R = 0.526, p < 0.001). Moreover, the percentage of CD8+ CXCR2-expressing cells was higher in HAM/TSP patients compared to ACs and HCs (p < 0.05, p < 0.01, respectively). Although the percentage of CD4+ CXCR2-expressing cells was higher in HAM/TSP patients than in ACs and HCs, a significant difference was only found between HAM/TSP patients and HCs (p < 0.05). No significant difference in the CXCR1 mRNA expression was observed in the studied groups. The frequency of the CD8+ CXCR1- and CD4+ CXCR1-expressing cells was significantly lower in HAM/TSP patients than in ACs and HCs (p < 0.001 and p < 0.01, respectively). In conclusion, the high frequency of CXCR2 CD8+ T cells and the high levels of CXCR2 mRNA expression in HAM/TSP patients are associated with disease pathogenesis, while the high frequencies of CXCR1 T cells in ACs might suggest that these cells act as effector CD8 T cells and are involved in controlling the viral spread and modulation of the immune response.
引用
收藏
页码:641 / 650
页数:9
相关论文
共 135 条
  • [1] Bangham CR(2000)The immune response to HTLV-I Curr Opin Immunol 12 397-402
  • [2] Verdonck K(2007)Human T-lymphotropic virus 1: recent knowledge about an ancient infection Lancet Infect Dis 7 266-281
  • [3] Gonzalez E(2011)High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey J Clin Virol 52 172-176
  • [4] Van Dooren S(2008)How does HTLV-I persist despite a strong cell-mediated immune response? Trends Immunol 29 4-11
  • [5] Rafatpanah H(2010)Neurodegeneration in autoimmune CNS inflammation Exp Neurol 225 9-17
  • [6] Hedayati-Moghaddam MR(2010)Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology Neuropathology 30 480-485
  • [7] Fathimoghadam F(2004)Human T cell lymphotropic Virus type I (HTLV-I)-specific CD4 + T cells: immunodominance hierarchy and preferential infection with HTLV-I J Immunol 172 1735-1743
  • [8] Asquith B(2008)HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network Inflamm Allergy Drug Targets 7 98-107
  • [9] Bangham CR(2010)Neuroimmunity of HTLV-I Infection J Neuroimmune Pharmacol 5 310-325
  • [10] Herz J(2008)Chemokines and leukocyte traffic Nat Immunol 9 949-952